Trial: 202010093

A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)

Phase

II

Principal Investigator

Keller, Jesse

Disease Site

Melanoma, Skin

Learn more about this study at: clinicaltrials.gov